Christie M,？ Oehler M K. Molecular pathology of epithelial ovarian cancer[J].J Br Menopause Soc, 2006, 12(2): 57-63. [2]Koshiyama M, Matsumura N, Konishi I. Recent concepts of ovarian carcinogenesis:？ type Ⅰ and type Ⅱ[J].Biomed Res Int,？ 2014,？ 2014: 934261. [3]张旭, 李刚. 鸟苷酸交换因子C3G对心肌细胞生存力的影响及其可能机制[J]. 第二军医大学学报, 2012, 33(11): 1172-1177. [4]Lengyel E. Ovarian cancer development and metastasis[J]. Am J Pathol,？ 2010,？ 177(3): 1053-1064. [5]Chrzanowska-Wodnicka M. Regulation of angiogenesis by a small GTPase Rap1[J].Vascul Pharmacol,？ 2010,？ 53(1/2): 1-10. [6]Radha V,？ Mitra A,？ Dayma K,？ et al. Signalling to actin:？ role of C3G,？ a multitasking guanine-nucleotide-exchange factor [J]. Biosci Rep,？ 2011,？ 31(4): 231-244. [7]Birukova A A,？ Tian X,？ Tian Y,？ et al. Rap-afadin axis in control of Rho signaling and endothelial barrier recovery[J]. Mol Biol Cell,？ 2013,？ 24(17): 2678-2688. [8]Maia V,？ Ortiz-Rivero S,？ Sanz M,？ et al. C3G forms complexes with Bcr-Abl and p38α MAPK at the focal adhesions in chronic myeloid leukemia cells:？ implication in the regulation of leukemic cell adhesion[J]. Cell Commun Signal, 2013, 11(1): 9. [9]Kloog Y,？ Mor A. Cytotoxic-T-lymphocyte antigen 4 receptor signaling for lymphocyte adhesion is mediated by C3G and Rap1[J]. Mol Cell Biol,？ 2014,？ 34(6): 978-988. [10]高一萌,？ 张 瑜,？ 李文燕,？ 等. C3G/Rap1和Dock180/Rac1信号通路在卵巢癌浸润中的作用[J]. 第三军医大学学报,？ 2012,？ 34(11):？ 1031-1034. [11]罗淑娟,？ 车亚玲,？ 彭慧娟,？ 等. C3G在卵巢癌组织中的表达及其在 SKOV3 细胞增殖中的作用[J]. 第三军医大学学报,？ 2013,？ 35(14):？ 1471-1479. [12]Kurman R J, Shih IeM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer——shifting the paradigm[J]. Hum Pathol, 2011, 42(7): 918-931. [13]Hills CA,？ Kelland LR,？ Abel G,？ et al. Biological properties of ten human ovarian carcinoma cell lines:？ calibration ？in vitro？ against four platinum complexes[J]. Br J Cancer,？ 1989,？ 59(4): 527-534. [14]Chen H,？ Wu X,？ Pan Z K,？ et al. Integrity of SOS1/EPS8/ABI1 tri-complex determines ovarian cancer metastasis[J]Cancer Res,？ 2010,？ 70(23): 9979-9990. [15]Dayma K,？ Ramadhas A,？ Sasikumar K,？ et al. Reciprocal negative regulation between the guanine nucleotide exchange factor C3G and β-catenin[J].Genes Cancer 2012, 3(9/10): 564-577. [16]Lutgendorf S K,？ Lamkin D M,？ Jennings N B,？ et al. Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma[J]. Clin Cancer Res,？ 2008,？ 14(21):？ 6839-6846. [17]Kessenbrock K,？ Plaks V,？ Werb Z. Matrix metalloproteinases:？ regulators of the tumor microenvironment[J]. Cell,？ 2010,？ 141(1):？ 52-67. [18]Guvakova M A,？ Lee W S,？ Furstenau D K,？ et al. The small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor Ⅰ[J]. Biochem J,？ 2014,？ 463(2): 257-270. [19]Liu E,？ Thant A A,？ Kikkawa F,？ et al. The Ras-mitogen-activated protein kinase pathway is critical for the activation of matrix metalloproteinase secretion and the invasiveness in v-crk-transformed 3Y1[J].Cancer Res, 2000, 60(9): 2361-2364. [20]Che Y L,？ Luo S J,？ Li G,？ et al. The C3G/Rap1 pathway promotes secretion of MMP-2 and MMP-9 and is involved in serous ovarian cancer metastasis[J]. Cancer Lett,？ 2015,？ 359(2): 241-249. [21]Brown P O,？ Palmer C. The preclinical natural history of serous ovarian cancer:？ defining the target for early detection[J]. PLoS Med,？ 2009,？ 6(7): e1000114.
